Murine models of idiopathic inflammatory myopathy
Idiopathic inflammatory myopathies (IIMs) are characterized by inflammation of muscles and other organs. Several myositis-specific autoantibodies (MSAs) have been identified in IIMs and were found to be associated with distinct clinical features ...
Risa Konishi +2 more
doaj +2 more sources
Belimumab treatment of adult idiopathic inflammatory myopathy. [PDF]
OBJECTIVE To evaluate belimumab addition to standard of care (SoC) in patents with refractory Idiopathic Inflammatory Myopathy (IIM). METHODS We conducted a 40-week multicentre randomized, double-blind, placebo-controlled trial with 1:1 IV belimumab 10
Marder G +9 more
europepmc +2 more sources
The value of myositis-specific autoantibodies in the diagnosis of idiopathic inflammatory myopathy and tumor risk prediction [PDF]
Objective To investigate the value of myositis-specific autoantibodies in the diagnosis of idiopathic inflammatory myopathy and tumor risk prediction in patients with clinically suspected idiopathic inflammatory myopathy. Methods This retrospective study
Lili Shi +5 more
doaj +2 more sources
Idiopathic inflammatory myopathy and non-coding RNA [PDF]
Idiopathic inflammatory myopathies (IIMs) are common autoimmune diseases that affect skeletal muscle quality and function. The lack of an early diagnosis and treatment can lead to irreversible muscle damage.
Yang Yang +5 more
doaj +2 more sources
Muscle Tissue Transcriptome of Idiopathic Inflammatory Myopathy Reflects the Muscle Damage Process by Monocytes and Presence of Skin Lesions. [PDF]
We aim to investigate transcriptomic and immunophenotypic features of muscle specimens from patients with idiopathic inflammatory myopathy (IIM).
Izuka S +21 more
europepmc +2 more sources
Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study. [PDF]
ObjectiveThe coronavirus disease pandemic brought unknown challenges to patients with idiopathic inflammatory myopathy, who are often heavily immunosuppressed and have comorbidities.
Ying Li +9 more
doaj +2 more sources
Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial. [PDF]
Our objective was to evaluate the efficacy and safety of subcutaneous (SC) abatacept and standard of care (SOC) for the treatment of idiopathic inflammatory myopathy (IIM) over 52 weeks.
Aggarwal R +5 more
europepmc +2 more sources
Cardiac arrest in seronegative idiopathic inflammatory myopathy: a case report. [PDF]
Srivatsav V, Khan A, Wardell S.
europepmc +3 more sources
The advance of idiopathic inflammatory myopathy
DOI: 10.3969/j.issn.1672-6731.2016.10 ...
Yun YUAN
doaj +1 more source

